Omnicell Executive Compensation (FY25)
OMCL · Executive and director compensation, fiscal 2022 to 2025
The paid brief on Omnicell
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
Data as of September 7, 2026Latest filing (8-K): May 26, 2026
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
$1,500Get the executive brief
224 figures on this page: 213 cited to the filing that reported them, 11 calculated from figures it prints. See the citations
More on Omnicell
Five data products on this company. Each one is requested through the developer setup page.
- Peer Disclosure Audit$5The comparison companies this board named, each one tied to the filing that lists it.How to get Peer Disclosure Audit
- Governance Provisions PullfreeThe governance provisions as the proxy states them: board leadership, committee membership, and shareholder rights.How to get Governance Provisions Pull
- Say-on-Pay Risk Signal$9A risk band for the next say-on-pay vote, with the support history and the peer comparison behind it.How to get Say-on-Pay Risk Signal
- NEO Comp Report$24Every named executive officer’s pay by element and year, with the citation behind each figure.How to get NEO Comp Report
- Board Comp Report$24What each non-employee director was paid, the standing fee schedule, and the equity each one holds at year end.How to get Board Comp Report
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Randall Lipps: $8,174,639 → $7,531,852 (7.9% lower)
CEO pay ratio: 79:1 → 70:1 (11.4% lower)
Frequently asked questions
Answers drawn from the data on this page.
Who is Omnicell's chief executive and what were they paid?
Total compensation for Randall Lipps, Chairman, President and Chief Executive Officer, came to $7,531,852 in fiscal 2025. Lipps' total moved 7.9% lower from the $8,174,639 reported for fiscal 2024.
What was Omnicell's say-on-pay result?
For fiscal 2025, the say-on-pay proposal drew 96.0% support at the meeting held May 19, 2026.
Which companies are in Omnicell's peer group?
The disclosed peer group includes ACI Worldwide, Inc., Avanos Medical, Inc., Blackbaud Inc, CONMED Corporation and Evolent Health, Inc., among others.
What is Omnicell's chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 70:1, against median employee compensation of $106,853.
Executive compensation
Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Randall Lipps Chairman, President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Peter Kuipers Executive Vice President and Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Scott Seidelmann Executive Vice President, Chief Commercial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Christine Mellon Executive Vice President, Chief Administrative & People Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Dan Johnston former, Executive Vice President, Chief Legal and Administrative Officer Departed during or after this year | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Corey Manley Senior Vice President, Chief Legal Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2024
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Randall Lipps Chairman, President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Nchacha Etta Executive Vice President, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Nnamdi Njoku Executive Vice President, Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Corey Manley Executive Vice President, Chief Legal and Administrative Officer | ◇ | ◇ | ◇ | — | ◇ | — | ◇ | ◇ |
Fiscal 2025
| Officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|---|
Randall Lipps Chairman, President and Chief Executive Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Nnamdi Njoku Executive Vice President, Chief Operating Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Corey Manley Executive Vice President, Chief Legal and Administrative Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
Nchacha Etta Former Executive Vice President, Chief Financial Officer Departed during or after this year | ◇ | — | — | — | ◇ | — | ◇ | ◇ |
H. Baird Radford Executive Vice President, Chief Financial Officer | ◇ | — | ◇ | — | ◇ | — | ◇ | ◇ |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.
Equity awards granted
Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
| Officer | Award | Grant date | Threshold units | Target units | Units granted | Maximum units | Exercise price | Grant date fair value |
|---|---|---|---|---|---|---|---|---|
| Baird Radford | PSU | ◇ | — | ◇ | — | — withheld | — | ◇ |
| Corey J. Manley | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Corey J. Manley | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Nnamdi T. Njoku | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Nnamdi T. Njoku | RSU | ◇ | — | — | ◇ | — | — | ◇ |
| Randall A. Lipps | PSU | ◇ | ◇ | ◇ | — | ◇ | — | ◇ |
| Randall A. Lipps | RSU | ◇ | — | — | ◇ | — | — | ◇ |
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.
Outstanding awards
Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
| Officer | Award | Unvested units | Market value of unvested units | Exercise price | Expires |
|---|---|---|---|---|---|
| Corey Manley | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Nnamdi Njoku | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| PSU | ◇ | ◇ | — | — | |
| Nchacha Etta | RSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| Randall Lipps | PSU | ◇ | ◇ | — | — |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| RSU | ◇ | ◇ | — | — | |
| Baird Radford | RSU | ◇ | ◇ | — | — |
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Severance and change in control
The terms as written in the agreements.
Corey Manley
Executive Vice President, Chief Legal and Administrative Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance cash amount | ◇ |
H. Baird Radford
Executive Vice President, Chief Financial Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance cash amount | ◇ |
Nchacha Etta
Former Executive Vice President, Chief Financial Officer · Severance agreement · citing a 2025 filing
| Severance multiple | ◇ |
| Severance cash amount | ◇ |
| Change-in-control trigger | ◇ |
| Equity acceleration on change in control | ◇ |
| Benefits continuation | ◇ |
| Excise tax treatment | ◇ |
| Non-solicit period | ◇ |
Nnamdi Njoku
Executive Vice President, Chief Operating Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance cash amount | ◇ |
Randall Lipps
Chairman, President and Chief Executive Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
| Severance cash amount | ◇ |
Director compensation
What each non-employee director was paid.
Fiscal 2025
| Director | Fees earned in cash | Stock awards | Option awards | Non-equity incentive | Pension and deferred earnings | All other compensation | Total |
|---|---|---|---|---|---|---|---|
Joanne B. Bauer Lead independent director | ◇ | ◇ | — | — | — | — | ◇ |
Mary A. Garrett | ◇ | ◇ | — | — | — | — | ◇ |
Bruce E. Scott | ◇ | ◇ | — | — | — | — | ◇ |
Robin G. Seim | ◇ | ◇ | — | — | — | — | ◇ |
Mark W. Parrish | ◇ | ◇ | — | — | — | — | ◇ |
Eileen J. Voynick | ◇ | ◇ | — | — | — | — | ◇ |
Edward P. Bousa | ◇ | ◇ | — | — | — | — | ◇ |
Kaushik Bobby Ghoshal | ◇ | ◇ | — | — | — | — | ◇ |
Randall A. Lipps served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.
Director fee schedule
The standing retainers and premiums the board pays, as published.
| Board equity retainer | ◇ |
| Lead independent director premium | ◇ |
| Audit committee chair | ◇ |
| Audit committee member | ◇ |
| Compensation committee chair | ◇ |
| Compensation committee member | ◇ |
| Nominating and governance chair | ◇ |
| Nominating and governance member | ◇ |
Disclosed peer group
The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
- ACI Worldwide, Inc. ACIW
- Avanos Medical, Inc. AVNS
- Blackbaud Inc BLKB
- CONMED Corporation CNMD
- Evolent Health, Inc. EVH
- Globus Medical, Inc GMED
- GoodRx Holdings, Inc. GDRX
- Haemonetics Corporation HAE
- HealthEquity, Inc. HQY
- ICU Medical, Inc. ICUI
- Inspire Medical Systems, Inc. INSP
- Integer Holdings Corporation ITGR
- Integra LifeSciences Holdings Corporation IART
- LivaNova PLC LIVN
- Masimo Corp. MASI
- MultiPlan, Inc. symbol not shown
- Nutanix, Inc. NTNX
- Orthofix Medical Inc. OFIX
- Pegasystems Inc. PEGA
- Tandem Diabetes Care, Inc. TNDM
Say-on-pay history
Shareholder support for the compensation program, by year.
| Year | Meeting | Support | Votes for | Votes against | Abstentions |
|---|---|---|---|---|---|
| 2025 | May 19, 2026 | = | ◇ | ◇ | ◇ |
| 2024 | May 21, 2025 | = | ◇ | ◇ | ◇ |
| 2023 | May 21, 2024 | = | ◇ | ◇ | ◇ |
| 2022 | May 23, 2023 | = | ◇ | ◇ | ◇ |
| 2021 | May 24, 2022 | = | ◇ | ◇ | ◇ |
| 2020 | May 25, 2021 | = | ◇ | ◇ | ◇ |
| 2019 | May 26, 2020 | = | ◇ | ◇ | ◇ |
| 2018 | May 14, 2019 | = | ◇ | ◇ | ◇ |
| 2017 | May 15, 2018 | = | ◇ | ◇ | ◇ |
| 2016 | May 23, 2017 | = | ◇ | ◇ | ◇ |
| 2015 | May 24, 2016 | = | ◇ | ◇ | ◇ |
Chief executive pay ratio
As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
What this page does not include
Everything above is a fact Omnicell disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Omnicell sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion IntelligenceAdviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about accessMultiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion IntelligenceCitations
Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
224 figures on this page: 213 cited to the filing that reported them, 11 calculated from figures it prints.
213 cited to the filing
11 calculated from the filing
Documents cited
- 0001104659-26-066316
- 0001104659-26-0426312025 SUMMARY COMPENSATION TABLE · CEO Pay Ratio · Compensation Discussion and Analysis · DIRECTOR COMPENSATION · and 3 more sections
- 0001104659-25-052464
- 0001104659-25-0317502024 SUMMARY COMPENSATION TABLE
- 0001104659-24-065130
- 0000926326-23-000020
- 0001104659-23-0427032022 SUMMARY COMPENSATION TABLE
- 0000926326-22-000020
- 0000926326-21-000015
- 0000926326-20-000017
- 0000926326-19-000015
- 0001104659-18-033801
- 0000926326-17-000019
- 0000926326-16-000060
- 0001104659-25-056908EX-10.1
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Omnicell executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/OMCL (accessed 2026).
Short form: data: Velarion
The paid brief for Omnicell
Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $1,200 for the board report; $2,400 for both.
15 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Omnicell and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Peers Omnicell discloses
The companies named in OMCL's own disclosed peer group.
ACI Worldwide, Inc.Avanos Medical, Inc.Blackbaud IncCONMED CorporationEvolent Health, Inc.Globus Medical, IncGoodRx Holdings, Inc.Haemonetics CorporationHealthEquity, Inc.ICU Medical, Inc.Inspire Medical Systems, Inc.Integer Holdings CorporationIntegra LifeSciences Holdings CorporationLivaNova PLCMasimo Corp.Nutanix, Inc.Orthofix Medical Inc.Pegasystems Inc.Tandem Diabetes Care, Inc.
Terms on this page
Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.
Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
author = {{Velarion Company Intelligence}},
title = {Velarion database: executive and board compensation data},
year = {2026},
version = {2026Q3},
doi = {10.5281/zenodo.22283854},
publisher = {Zenodo},
url = {https://doi.org/10.5281/zenodo.22283854}
}